Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00581633 · ClinicalTrials.gov registry record · NA

Acute Salt Handling in Orthostatic Intolerance

A NA study of Postural Tachycardia Syndrome and Orthostatic Intolerance, sponsored by Vanderbilt University.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00581633 is a NA study of Postural Tachycardia Syndrome and Orthostatic Intolerance that is active but no longer recruiting, run by Vanderbilt University. The registered enrollment target is 30 participants, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00581633, a NA study of Postural Tachycardia Syndrome and Orthostatic Intolerance, is active but no longer recruiting, sponsored by Vanderbilt University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The investigators will test the hypothesis that patients with chronic orthostatic intolerance or postural orthostatic tachycardia syndrome (OI or POTS) will be unable to conserve urinary sodium as compared to healthy control subjects.

Interventions

  • OTHER normal saline (0.9%)

Study Locations (1)

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2007-02
Est. Completion 2029-12
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT00581633

The ClinicalTrials.gov registry entry for NCT00581633 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (63% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 1 intervention - of which normal saline (0.9%) is the first listed.

NCT00581633 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00581633 about?

NCT00581633 is a clinical study titled "Acute Salt Handling in Orthostatic Intolerance". The investigators will test the hypothesis that patients with chronic orthostatic intolerance or postural orthostatic tachycardia syndrome (OI or POTS) will be unable to conserve urinary sodium as compared to healthy control subjects.

What is the current status of trial NCT00581633?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2007-02. Estimated completion is 2029-12.

What conditions does trial NCT00581633 study?

This clinical trial studies the following conditions: Postural Tachycardia Syndrome, Orthostatic Intolerance, Orthostatic Tachycardia.

What interventions are being tested in trial NCT00581633?

The interventions under investigation include: normal saline (0.9%) (OTHER).

Who is sponsoring clinical trial NCT00581633?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00581633 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postural Tachycardia Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.